Coherus Biosciences | CHRS - Credores Comerciais

Preço das Ações
1.56
Mudança Diária
0.04 2.63%
Mensal
-3.70%
Anual
51.46%
Q1 Previsão
1.47




Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Akebia Therapeutics USD 21.18M 11.1M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 45.36M 8.64M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Baxter International USD 999M 46M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Fujifilm JPY 308.06B 17.41B 2025-12
Gilead Sciences USD 808M 226M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Merck USD 4.15B 102M 2025-09
Myriad Genetics USD 30M 1.8M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xencor USD 10.83M 1.75M 2025-12
Zoetis USD 487M 77M 2025-12